FAST BioMedical Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

FAST BioMedical General Information

Description

Developer of clinical-stage medical technology designed to measure blood volume and kidney function in a clinically viable way. The company's technology uses a fluorescent compound to identify signs and symptoms of kidney infections faster than a traditional lab test, enabling physicians to detect acute kidney failure by measuring the presence through markers that are injected into a patient's bloodstream and fluoresce with the use of the device.

Contact Information

Formerly Known As
Pharmaco Photonics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9075 North Meridian Street
  • Suite 200
  • Indianapolis, IN 46260
  • United States
+1 (866)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 9075 North Meridian Street
  • Suite 200
  • Indianapolis, IN 46260
  • United States
+1 (866)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FAST BioMedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Secondary Transaction - Private 01-Jan-2022 Completed Clinical Trials - Phase 4
14. Later Stage VC (Series B) Completed Clinical Trials - Phase 4
13. Later Stage VC (Series A2) 09-Aug-2019 Completed Clinical Trials - Phase 4
12. Angel (individual) 01-Mar-2017 Completed Clinical Trials - Phase 4
11. Later Stage VC (Series A2) 01-Feb-2017 Completed Clinical Trials - Phase 4
10. Grant 02-Jan-2017 Completed Clinical Trials - Phase 4
9. Later Stage VC (Series A) 01-Jan-2017 Completed Clinical Trials - Phase 4
8. Later Stage VC 01-Jan-2017 Completed Clinical Trials - Phase 4
7. Grant 01-Jan-2017 $1.1M $8.27M Completed Clinical Trials - Phase 4
6. Later Stage VC (Series A1) 30-Aug-2016 $1.53M $8.27M Completed Clinical Trials - Phase 4
To view FAST BioMedical’s complete valuation and funding history, request access »

FAST BioMedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
To view FAST BioMedical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

FAST BioMedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of clinical-stage medical technology designed to measure blood volume and kidney function in a clinically viab
Diagnostic Equipment
Indianapolis, IN
2 As of 2023

Saint Louis, MO
 

Oak Ridge, TN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FAST BioMedical Competitors (5)

One of FAST BioMedical’s 5 competitors is MediBeacon, a Venture Capital-Backed company based in Saint Louis, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediBeacon Venture Capital-Backed Saint Louis, MO
Daxor Corporation Oak Ridge, TN
Avvio Medical Venture Capital-Backed San Francisco, CA
Transonic Private Debt Financed Ithaca, NY
Millar Private Debt Financed Houston, TX
You’re viewing 5 of 5 competitors. Get the full list »

FAST BioMedical Patents

FAST BioMedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019353114-A1 Method and apparatus for determining interstitial volume Inactive 05-Oct-2018
CA-3114930-A1 Method and apparatus for determining interstitial volume Inactive 05-Oct-2018
US-20200174018-A1 Method and apparatus for determining interstitial volume Inactive 05-Oct-2018
EP-3860460-A4 Method and apparatus for determining interstitial volume Inactive 05-Oct-2018
EP-3860460-A1 Method and apparatus for determining interstitial volume Inactive 05-Oct-2018 G01N33/6893
To view FAST BioMedical’s complete patent history, request access »

FAST BioMedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FAST BioMedical Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
316 Investments Venture Capital Minority
Ellipsis Ventures Venture Capital Minority
National Institute of Diabetes and Digestive and Kidney Diseases Government
U.S. Department of Health and Human Services Government
Ariel Savannah Angel Partners Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

FAST BioMedical FAQs

  • When was FAST BioMedical founded?

    FAST BioMedical was founded in 2006.

  • Where is FAST BioMedical headquartered?

    FAST BioMedical is headquartered in Indianapolis, IN.

  • What is the size of FAST BioMedical?

    FAST BioMedical has 2 total employees.

  • What industry is FAST BioMedical in?

    FAST BioMedical’s primary industry is Diagnostic Equipment.

  • Is FAST BioMedical a private or public company?

    FAST BioMedical is a Private company.

  • What is FAST BioMedical’s current revenue?

    The current revenue for FAST BioMedical is .

  • How much funding has FAST BioMedical raised over time?

    FAST BioMedical has raised $34.7M.

  • Who are FAST BioMedical’s investors?

    316 Investments, Ellipsis Ventures, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human Services, and Ariel Savannah Angel Partners are 5 of 10 investors who have invested in FAST BioMedical.

  • Who are FAST BioMedical’s competitors?

    MediBeacon, Daxor, Avvio Medical, Transonic, and Millar are competitors of FAST BioMedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »